107 research outputs found

    A Study on Enhancement for the Medical Response System of the Korea Coast Guard in order to Improve Stability on Duty

    Get PDF
    The purpose of this study is to improve the stability of the KCG Injured officer on duty. Therefore, it is necessary to reveal the actual conditions and problems of the field Emergency Medical Response System for KCG Injured officer, and to suggest ways to improve the Medical Response System such as cooperation and training with related organizations, rehabilitation program for injured officer. In this study, we classify the marital characteristics of the KCG Injured officer by carrying out dangerous duties in the barren oceans to confirm the importance of the Medical Response System for injured persons, in order to understand the actual condition, we analyzed the actual condition of KCG, and analyzed the problems by analyzing the effect of post - traumatic stress disorder on KCG. In Korea, Medical Response System in the Pre-hospital stage are investigated in Korea, and there is a high frequency and risk of being injured officer on duty such as KCG. Emergency Medical Response System of the injured officer of the military, those of neighboring Japan Coast Guard, which has high geographical and cultural similarity with us and performs their duties, was investigated and compared. The analysis of the KCG Injured officer medical response survey, the comparison of the Emergency Medical Response System of similar organizations, and the analysis of related research data, suggests the improvement direction of the Medical Response System in terms of structure side. This study is a study on KCG officers' surveys on maritime emergency medical response, suggesting a comprehensive Medical Response System for injured officers such as rehabilitation and rehabilitation after disaster treatment and disaster prevention policy There is great significance.|λ³Έ μ—°κ΅¬λŠ” κ·Έλ™μ•ˆ λ°œμƒν•΄μ™”λ˜ ν•΄μ–‘κ²½μ°°κ΄€μ˜ 직무 μˆ˜ν–‰ 쀑 λΆ€μƒμžμ— λŒ€ν•œ μ•ˆμ •μ„± ν–₯상을 μœ„ν•œ 것이 λͺ©μ μ΄λ‹€. λ”°λΌμ„œ λΆ€μƒμžμ— λŒ€ν•œ ν˜„μž₯ μ‘κΈ‰μ˜λ£Œμ˜ μ‹€νƒœμ™€ λ¬Έμ œμ μ„ λ„μΆœν•˜κ³ , μœ κ΄€κΈ°κ΄€κ³Όμ˜ ν˜‘λ ₯ 및 ν›ˆλ ¨, λΆ€μƒμžμ— λŒ€ν•œ μž¬ν™œ 및 μ‚¬νšŒ λ³΅κ·€ν”„λ‘œκ·Έλž¨ λ“± μ˜λ£ŒλŒ€μ‘μ²΄κ³„μ˜ κ°œμ„ λ°©ν–₯을 μ œμ‹œν•˜κ³ μžν•œλ‹€. λ”°λΌμ„œ 금번 μ—°κ΅¬μ—μ„œλŠ” μ²™λ°•ν•œ ν•΄μ–‘ μ†μ—μ„œ μœ„ν—˜ν•œ 직무λ₯Ό μˆ˜ν–‰ν•˜λ‹€ 뢀상을 λ‹Ήν•˜λŠ” ν•΄μ–‘κ²½μ°°μ˜ 직무적 νŠΉμ„±μ„ λΆ„λ₯˜ν•˜μ—¬ λΆ€μƒμžμ— λŒ€ν•œ 의료 λŒ€μ‘μ²΄κ³„μ˜ μ€‘μš”μ„±μ„ ν™•μΈν•˜κ³ , ν•΄μ–‘κ²½μ°° λΆ€μƒμž λ°œμƒ μ‹œ ν˜„μž¬μ˜ μ‘κΈ‰μ˜λ£Œ λŒ€μ‘μ²΄κ³„μ˜ μ •ν™•ν•œ μ‹€νƒœλ₯Ό νŒŒμ•…ν•˜κΈ° μœ„ν•΄ ν•΄μ–‘κ²½μ°° μ‘κΈ‰μ˜λ£Œ λŒ€μ‘κ΄€λ¦¬μ²΄κ³„ μ‹€νƒœμ‘°μ‚¬ 및 뢄석, ν•΄μ–‘κ²½μ°°νŠΉκ³΅λŒ€ 외상후 슀트레슀 μž₯μ• μ˜ν–₯ 쑰사 뢄석을 톡해 λ¬Έμ œμ μ„ λΆ„μ„ν•˜μ˜€λ‹€. μš°λ¦¬λ‚˜λΌμ˜ μ‘κΈ‰ν™˜μžμ— λŒ€ν•œ 병원전 λ‹¨κ³„μ—μ„œμ˜ μ‘κΈ‰μ˜λ£Œ λŒ€μ‘μ²΄κ³„ 및 μ†Œλ°©μ€‘μ‹¬μ˜ μ‘κΈ‰μ˜λ£Œ λŒ€μ‘μ²΄κ³„λ₯Ό μ•Œμ•„λ³΄κ³ , ν•΄μ–‘κ²½μ°°κ³Ό 같이 ν˜„μž₯ 곡무 μˆ˜ν–‰ 쀑 뢀상을 λ‹Ήν•˜λŠ” λΉˆλ„λ‚˜ μœ„ν—˜μ„±μ΄ λ†’μ•„ 자체 μ‘κΈ‰μ˜λ£Œ λŒ€μ‘μ²΄κ³„λ₯Ό 운영 쀑인 ꡰ의 λΆ€μƒμž μ‘κΈ‰μ˜λ£Œ λŒ€μ‘μ²΄κ³„, μš°λ¦¬μ™€ 지리적·문화적 μœ μ‚¬μ„±μ΄ λ†’κ³  ν•΄μ–‘κ²½μ°°μ˜ 직무λ₯Ό μˆ˜ν–‰ν•˜κ³  μžˆλŠ” 이웃 일본 ν•΄μƒλ³΄μ•ˆμ²­μ˜ μ‘κΈ‰μ˜λ£Œ λŒ€μ‘μ²΄κ³„λ₯Ό μ‘°μ‚¬ν•˜μ—¬ 비ꡐ λΆ„μ„ν•˜μ˜€λ‹€. μ΄λŸ¬ν•œ ν•΄μ–‘κ²½μ°° λΆ€μƒμž μ˜λ£ŒλŒ€μ‘ μ‹€νƒœ 쑰사 뢄석, μœ μ‚¬κΈ°κ΄€μ˜ μ‘κΈ‰μ˜λ£Œ λŒ€μ‘μ²΄κ³„ 비ꡐ 및 κ΄€λ ¨ 연ꡬ 자료 λ“±μ˜ 뢄석을 톡해 ν•΄μ–‘κ²½μ°° λΆ€μƒμžμ— λŒ€ν•œ ꡬ쑰 μΈ‘λ©΄, κ³Όμ • μΈ‘λ©΄ 및 κ²°κ³Ό μΈ‘λ©΄μ—μ„œμ˜ μ˜λ£ŒλŒ€μ‘μ²΄κ³„μ— λŒ€ν•œ κ°œμ„  λ°©ν–₯을 μ œμ‹œν•˜μ˜€λ‹€. 이번 μ—°κ΅¬λŠ” 해양경찰관듀을 λŒ€μƒμœΌλ‘œ 해상 μ‘κΈ‰μ˜λ£Œ λŒ€μ‘μ— κ΄€ν•œ μ‹€νƒœ 쑰사에 λŒ€ν•œ μ—°κ΅¬μ΄μž, λΆ€μƒμž 치료 μ΄ν›„μ˜ μž¬ν™œ 및 μ‚¬νšŒλ³΅κ·€, μž¬ν•΄μ˜ˆλ°©μ •μ±… λΆ„μ•Ό λ“± λΆ€μƒμžμ— λŒ€ν•œ 쒅합적인 μ˜λ£ŒλŒ€μ‘ 체계에 κ΄€ν•œ λ°©μ•ˆμ„ μ œμ‹œν•˜μ˜€λ‹€λŠ”λ° 큰 μ˜μ˜κ°€ μžˆλ‹€.제1μž₯ μ„œλ‘  1 1.1 μ—°κ΅¬μ˜ λ°°κ²½κ³Ό ν•„μš”μ„± 1 1.2 μ—°κ΅¬μ˜ λͺ©μ  4 1.3 연ꡬ λ²”μœ„μ™€ 방법 4 1.3.1 μ—°κ΅¬μ˜ λ²”μœ„ 4 1.3.2 μ—°κ΅¬μ˜ 방법 5 제2μž₯ ν•΄μ–‘κ²½μ°°μ˜ 직무적 νŠΉμ„± 6 2.1 직무 μ˜μ—­μ˜ κ΄‘μ—­μ„± 7 2.2 ν•΄μ–‘μ˜ λ‹€μ–‘ν•œ 우발적 상황변화에 λŒ€ν•œ μ·¨μ•½μ„± 8 2.3 μΌλ°˜μ‚¬νšŒμ™€μ˜ 격리성 및 κ΄€μ‹¬μ—μ„œμ˜ μ†Œμ™Έμ„± 9 2.4 μ „λ¬Έμ„±κ³Ό μ§λ¬΄μœ ν˜•μ˜ λ‹€μ–‘μ„± 10 2.5 μ²™λ°•ν•œ ν•΄μ–‘μ—μ„œ ν•΄μ–‘κ²½μ°° μ§λ¬΄μˆ˜ν–‰μ˜ μœ„ν—˜μ„± 11 2.5.1 ν•΄μ–‘κ²½μ°°κ΄€ 직무 쀑 λΆ€μƒμž λŒ€μ‘ 사둀 11 2.5.2 ν•΄μ–‘κ²½μ°°κ΄€ 사고 사둀 14 제3μž₯ ν•΄μ–‘κ²½μ°° λΆ€μƒμž 의료 λŒ€μ‘μ²΄κ³„ μ‹€νƒœ 21 3.1 ν•΄μ–‘κ²½μ°° μ‘κΈ‰μ˜λ£Œ λŒ€μ‘ 관리체계 μ‹€νƒœ 쑰사 21 3.1.1 λΆ€μƒμž μ‘κΈ‰μ˜λ£Œ λŒ€μ‘ 관리 체계 κ°œμš” 23 3.1.2 ν•΄μ–‘κ²½μ°° λΆ€μƒμž 의료 λŒ€μ‘ μ„€λ¬Έ 쑰사 κ²°κ³Ό 38 3.1.3 λΆ€μƒμž 의료 λŒ€μ‘κ΄€λ¦¬ 체계 문제점 64 3.2 ν•΄μ–‘κ²½μ°°νŠΉκ³΅λŒ€ 외상후 슀트레슀 μž₯μ•  영ν–₯ 쑰사 70 3.2.1 외상후 슀트레슀 μž₯μ•  영ν–₯ 쑰사 κ°œμš” 71 3.2.2 외상후 슀트레슀 μž₯μ•  영ν–₯ 쑰사 뢄석 κ²°κ³Ό 74 3.2.3 외상후 슀트레슀 μž₯μ•  영ν–₯ 문제점 및 μš”μ•½ 78 3.3 μ†Œκ²° 81 3.3.1 κ²°κ³Ό μš”μ•½ 81 3.3.2 μš”μΈ 뢄석 83 제4μž₯ μœ μ‚¬κΈ°κ΄€μ˜ μ‘κΈ‰μ˜λ£Œ λŒ€μ‘μ²΄κ³„ 비ꡐ 97 4.1 μš°λ¦¬λ‚˜λΌ μ‘κΈ‰μ˜λ£Œ λŒ€μ‘μ²΄κ³„ 97 4.1.1 μ‘κΈ‰μ˜λ£Œμ˜ κ°œλ…κ³Ό 역사 97 4.1.2 μ‘κΈ‰μ˜λ£Œμ²΄κ³„μ˜ κ΅¬μ„±μš”μ†Œ 105 4.2 μ†Œλ°©(119 κ΅¬κΈ‰λŒ€) μ‘κΈ‰μ˜λ£Œ λŒ€μ‘μ²΄κ³„ 116 4.2.1 μ†Œλ°©μ‘°μ§ 및 인λ ₯ 116 4.2.2 119 κ΅¬κΈ‰λŒ€ ν˜„ν™© 118 4.2.3 119 κ΅¬κΈ‰λŒ€ 운영 체계 119 4.3 κ΅° λΆ€μƒμž μ‘κΈ‰μ˜λ£Œ λŒ€μ‘μ²΄κ³„ 120 4.3.1 κ΄€λ ¨ κ·Όκ±° 121 4.3.2 κ΅° λΆ€μƒμž λŒ€μ‘κ΄€λ¦¬μ²΄κ³„ 121 4.4 일본 ν•΄μƒλ³΄μ•ˆμ²­ μ‘κΈ‰μ˜λ£Œ λŒ€μ‘μ²΄κ³„ 126 4.4.1 ν•΄μƒλ³΄μ•ˆμ²­μ˜ μ‘κΈ‰μ˜λ£Œ λŒ€μ‘μ²΄κ³„ 126 4.4.2 ν•΄μƒλ³΄μ•ˆμ²­ 해상 ν™˜μžμ— λŒ€ν•œ μ‘κΈ‰μ˜λ£Œ λŒ€μ‘μ²΄κ³„μ˜ λ³€ν™” 127 제5μž₯ ν•΄μ–‘κ²½μ°° λΆ€μƒμž μ˜λ£ŒλŒ€μ‘μ²΄κ³„ λ°œμ „ λ°©ν–₯ 130 5.1 μ‘κΈ‰λŒ€μ‘ ꡬ쑰 μΈ‘λ©΄ 130 5.1.1 ν•΄μ–‘κ²½μ°°κ΄€ λΆ€μƒμž μ‘κΈ‰μ˜λ£Œμ²΄κ³„ 130 5.1.2 λΆ€μƒμž 응급 λŒ€μ‘ 쑰직 μ‹ μ„€ 및 인λ ₯ 확보 133 5.1.3 응급 λŒ€μ‘ μž₯λΉ„μ˜ ν™•μΆ© 136 5.1.4 μ‘κΈ‰λŒ€μ‘ μ²΄κ³„μ˜ 법적 κ·œμ • 보완 137 5.2 μ‘κΈ‰λŒ€μ‘ κ³Όμ • μΈ‘λ©΄ 138 5.2.1 λŒ€μ‘ 합동 ν›ˆλ ¨ κ°•ν™” 및 λŒ€μ‘ μžμ‚° 곡유 ν™œμ„±ν™” 138 5.2.2 직무 μˆ˜ν–‰ μ „ 예방 ꡐ윑 및 μ‘κΈ‰λŒ€μ‘ 지침 마련 140 5.3 μ‘κΈ‰λŒ€μ‘ κ²°κ³Ό μΈ‘λ©΄ 141 5.3.1 λΆ€μƒμž μž¬ν™œ ν”„λ‘œκ·Έλž¨ 수립 141 5.3.2 μ‚°μ—…μ•ˆμ „λ³΄κ±΄μ— μ€€ν•˜λŠ” μž¬ν•΄ 예방 μ •μ±… 적용 143 제6μž₯ κ²°λ‘  147Docto

    Porphyromonas gingivalis, Treponema denticola,

    Get PDF
    Dept. of Dentistry/석사[ν•œκΈ€] μΉ˜μ£Όμ—Όμ€ 치쑰골의 흑수λ₯Ό λ™λ°˜ν•˜λŠ” 염증성 μ§ˆν™˜μœΌλ‘œ μΉ˜μ€μ—°ν•˜ μΉ˜νƒœλ‚΄μ˜ μ—¬λŸ¬ μ’…λ₯˜μ˜ 미생물이 치쑰골 ν‘μˆ˜μ— 영ν–₯을 μ€€λ‹€. μ΄λŸ¬ν•œ μ—¬λŸ¬ μ’…λ₯˜μ˜ μΉ˜μ£Όλ³‘μΈμ²΄λ‘œ μΈν•˜μ—¬ λ°œμƒν•˜λŠ” μ—¬λŸ¬ νŒŒκ³¨μ„Έν¬ν˜•μ„± 인자 μ€‘μ—μ„œ κ³΅ν†΅λœ 인자λ₯Ό μ°ΎκΈ° μœ„ν•΄, 마우슀 λ‘κ°œκ³¨ κΈ°μ›μ˜ 쑰골세포와 골수 μ„Έν¬μ˜ ν˜Όν•©λ°°μ–‘μ—μ„œ μ„Έ μ’…λ₯˜μ˜ μΉ˜μ£Όλ³‘μΈμ²΄, 즉, Porphyromonas gingivalis, Treponema denticola 및 Treponema socranskii에 μ˜ν•œ νŒŒκ³¨μ„Έν¬ν˜•μ„± 기전을 κ΄€μ°°ν•˜μ˜€λ‹€. μ‘°κ³¨μ„Έν¬μ˜ interleukin (IL)-1b, tumor necrosis factor (TNF)-a, receptor activator of NF-kB ligand (RANKL) 및 prostaglandin E2 (PGE2)의 λ°œν˜„μ€ reverse transcriptase polymerase chain reaction (RT-PCR) 및 면역뢄석법을 ν†΅ν•˜μ—¬ κ΄€μ°°ν•˜μ˜€λ‹€. μ„Έ μ’…μ˜ μ„Έκ·  뢄쇄앑은 ν˜Όν•©λ°°μ–‘μ—μ„œ νŒŒκ³¨μ„Έν¬ν˜•μ„±μ„ μ΄‰μ§„ν•˜μ˜€κ³ , μ‘°κ³¨μ„Έν¬μ˜ RANKL, IL-1b 및 TNF-a의 mRNA λ°œν˜„ 그리고 PGE2 의 생성을 μ¦κ°€μ‹œμΌ°λ‹€. RANKL의 μ–΅μ œ 인자인 osteopotegerin (OPG)λŠ” 각 μ„Έκ·  뢄쇄앑에 μ˜ν•œ νŒŒκ³¨μ„Έν¬ν˜•μ„±μ„ μ™„μ „νžˆ μ–΅μ œν•˜μ˜€λ‹€. λ˜ν•œ PGE2 ν˜•μ„± μ–΅μ œ 인자인 indomethacin, anti-IL-1b antibody (Ab), 및 anti-TNF-a Abκ°€ λ”ν•΄μ‘Œμ„ λ•Œ 각각의 λ―Έμ„Έκ·  λΆ„μ‡„μ•‘μ˜ νŒŒκ³¨μ„Έν¬ ν˜•μ„±λŠ₯이 μ €ν•˜λ˜μ—ˆλ‹€. λ˜ν•œ, indomethacin, anti-IL-1b Ab, λ˜λŠ” anti-TNF-a AbλŠ” P. gingivalis, T. denticola, 및 T. socranskii 뢄쇄앑 으둜 처리된 쑰골 μ„Έν¬λ‚΄μ—μ„œ RANKL λ°œν˜„μ„ μ €ν•˜μ‹œμΌ°λ‹€. μ΄λŠ” P. gingivalis, T. denticola, 및 T. socranskiiκ°€ μ‘°κ³¨μ„Έν¬μ˜ RANKL의 λ°œν˜„μ„ μ¦κ°€μ‹œμΌœ νŒŒκ³¨μ„Έν¬ ν˜•μ„±μ„ μ΄‰μ§„ν•˜λ©°, μ΄λŸ¬ν•œ μ„Έ μ’…μ˜ 미생물에 μ˜ν•œ RANKL λ°œν˜„μ— IL-1b, TNF-a 및 PGE2 κ°€ 쀑간 맀개체둜 μž‘μš©ν•œλ‹€λŠ” 것을 보여주고 μžˆλ‹€. [영문] Periodontitis is an inflammatory disease that often leads to destruction of alveolar bone. Multiple species of bacteria in subgingival plaque are associated with bone destruction in periodontitis. In this kind of bone destruction, the osteoclast is known to play a key role. To determine the mediators which are involved in osteoclastogenesis by periodontopathogens, we studied the effect of three periodontopathogens, Porphyromonas gingivalis, Treponema denticola, and Treponema socranskii on osteoclastogenesis in coculture system of mouse calvaria derived osteoblastic cells and bone marrow cells. The expression of interleukin (IL)-1b, tumor necrosis factor (TNF)-a, receptor activator of NF-kB ligand (RANKL) and prostaglandin E2 (PGE2) in mouse calvaria cells was determined by reverse transcriptase-polymerase chain reaction (RT-PCR) or immunoassay. Sonicates of three bacteria induced osteoclast formation in coculture systems and the mRNA expression of IL-1b, TNF-a, and RANKL in osteoblastic cells. The production of PGE2 was increased by three bacteria sonicates. Addition of osteoprotegerin (OPG), which is an inhibitor of RANKL, in the cocultures resulted in the complete suppression of the induction of the osteoclast formation. Anti-IL-1b antibody (Ab), anti-TNF-a Ab and indomethacin, which is an inhibitor of PGE2, partially inhibited the induction of the osteoclast formation by each bacteria. In addition, indomethacin, anti-IL-1b Ab, or anti-TNF-a Ab decreased RANKL expression of osteoblastic cells treated with bacterial sonicates of P. gingivalis, T. denticola, and T. socranskii. These findings suggest that increased RANKL expression of osteoblastic cells may play an important role in the osteoclast formation induced by P. gingivalis, T. denticola, and T. socranskii and that PGE2, IL-1b, and TNF-a are mediators for the induction of RANKL expression by these bacteria.ope

    Current Analysis of Acintobacter baumannii Infection among Pediatric Patients in a Single-centered Study

    Get PDF
    Purpose : Acinetobacter baumannii is an aerobic, gram negative coccobacillus. Due to its pathogenicity and ability to accumulate diverse mechanisms of resistance, the importance of this organism is increasing. Many reports have targeted adults, and studies of pediatric patients are limited. This study aims to investigate the current status of A. baumannii infection in children. Methods : From January 2001 to December 2008, 505 patients hospitalized with A. baumannii infection were enrolled. Admission records for underlying disease, duration of hospitalization, previous antibiotic use, location of admission, presence of ventilator care, and resistance to antibiotics were retrospectively reviewed and analyzed. Results : Hemato-oncological disease and neurological disease were 30.6% and 24.3% of all cases; therefore, these were the most common underlying diseases of patients with A. baumannii infection. Prevalence of A. baumannii infection was 78.1% in patients with previous antibiotic use, which was higher than that of the group not using previous antibiotic. And prevalence of multi-drug resistant and pan-drug resistant A. baumannii infection was 76.4% and 38.3% in patients with ICU care, 76.8% and 38.9% with ventilator care, and these were higher than the others. Rate of resistance to all groups of antibiotics showed a gradual increase to over 50% in 2008. Multi-drug resistant A. baumannii was 63.5% and pan-drug resistant A. baumannii was 48.2% of all cases. Conclusion : Prevalence of A. baumannii infection and resistance to antibacterial agents of A. baumannii is increasing. Adequate use of antibiotics and infection control should be emphasized in pediatric patientsope

    Risk Factors for Neurologic Complications of Hand, Foot and Mouth Disease in the Republic of Korea, 2009

    Get PDF
    In 2009, the first outbreak of hand, foot and mouth disease (HFMD) or herpangina (HP) caused by enterovirus 71 occurred in the Republic of Korea. This study inquired into risk factors associated with complications of HFMD or HP. A retrospective medical records review was conducted on HFMD or HP patients for whom etiologic viruses had been verified in 2009. One hundred sixty-eight patients were examined for this investigation. Eighty patients were without complications while 88 were accompanied by complications, and 2 had expired. Enterovirus 71 subgenotype C4a was the most prevalent in number with 67 cases (54.9%). In the univariate analysis, the disease patterns of HFMD rather than HP, fever longer than 4 days, peak body temperature over 39℃, vomiting, headache, neurologic signs, serum glucose over 100 mg/dL, and having an enterovirus 71 as a causative virus were significant risk factors of the complications. After multiple logistic analysis, headache (Odds ratio [OR], 10.75; P < 0.001) and neurologic signs (OR, 42.76; P < 0.001) were found to be the most significant factors. Early detection and proper management of patients with aforementioned risk factors would be necessary in order to attain a better clinical outcome.ope

    Identification of Viral Pathogens for Lower Respiratory Tract Infection in Children at Seoul During Autumn and Winter Seasons of the Year of 2008-2009

    Get PDF
    Purpose: The Purposes of this study are to identify the circulating etiologic viruses of acute lower respiratory tract infection in children and to understand the relation with clinical diagnosis. Methods: We obtained a total of 418 nasopharyngeal aspirates from children admitted for their acute lower respiratory tract infections at three tertiary hospitals in Seoul from September 2008 to March 2009. We performed multiplex RT-PCR to identify 14 etiologic viruses and analyzed their emerging patterns and clinical features. Results: Average age of patients was 16.4 months old and the ratio of male to female was 1.36. Viruses were detected in 56.2% of a total of 418 samples. Respiratory syncytial virus (35%) was the most frequently detected and followed by human rhinovirus (22%), human bocavirus, adenovirus, human metapneumovirus, parainfluenza virus, influenza virus and human coronavirus. Co-infection reached 21.9 % of positive patients. Conclusion: When we manage the patients with acute lower respiratory infectious diseases, we should remind the role of various viral pathogens, which might be circulating by seasons and by local areasope

    Identification of Recombinant Human Rhinovirus A and C in Circulating Strains from Upper and Lower Respiratory Infections

    Get PDF
    Human rhinoviruses (HRVs), in the Enterovirus genus within the family Picornaviridae, are a highly prevalent cause of acute respiratory infection (ARI). Enteroviruses are genetically highly variable, and recombination between serotypes is known to be a major contribution to their diversity. Recently it was reported that recombination events in HRVs cause the diversity of HRV-C. This study analyzed parts of the viral genes spanning the 5β€² non- coding region (NCR) through to the viral protein (VP) encoding sequences of 105 HRV field isolates from 51 outpatient cases of Acute Respiratory Infectious Network (ARINET) and 54 inpatient cases of severe lower respiratory infection (SLRI) surveillance, in order to identify recombination in field samples. When analyzing parts of the 5β€²NCR and VP4/VP2 encoding sequences, we found intra- and interspecies recombinants in field strains of HRV-A and -C. Nineteen cases of recombination events (18.1%) were found among 105 field strains. For HRV-A, there were five cases (4.8%) of intraspecies recombination events and three cases (2.8%) of interspecies recombination events. For HRV-C, there were four cases (3.8%) of intraspecies recombination events and seven cases (6.7%) of interspecies recombination events. Recombination events were significantly more frequently observed in the ARINET samples (18 cases) than in the SLRI samples (1 case; P< 0.0001). The recombination breakpoints were located in nucleotides (nt) 472–554, which comprise stem-loop 5 in the internal ribosomal entry site (IRES), based on the HRV-B 35 sequence (accession no. FJ445187). Our findings regarding genomic recombination in circulating HRV-A and -C strains suggest that recombination might play a role in HRV fitness and could be a possible determinant of disease severity caused by various HRV infections in patients with ARI.ope

    Clinical Characteristic of Respiratory Tract Infections in Children during Pandemic Influenza (H1N1 2009) in Korea

    Get PDF
    BACKGROUND: Since initial emergence on pandemic influenza (H1N1 2009) in Mexico on March 2009, the first case of pandemic influenza (H1N1 2009) occured on 2 May 2009 in Korea. We describe the clinical characteristics of childhood patients from pandemic influenza (H1N1 2009) and other concurrent respiratory pathogens during early phase of the pandemic influenza in Korea. MATERIALS AND METHODS: We have retrospectively studied 959 patients under age of 15 years who have visited Department of Emergency Medicine for a diagnostic test of pandemic influenza (H1N1 2009) or treatment of flu-like illness between May and September of 2009. The pandemic influenza (H1N1 2009) was detected via real-time RT-PCR and other respiratory viruses were detected via multiplex RT-PCR. RESULTS: A total of 959 patients visited Department of Emergency Medicine at Severance Hospital. Of them, 562 were tested; 124 (12.7%) were positive for pandemic influenza (H1N1 2009). Confirmed patients of pandemic influenza (H1N1 2009) were relatively older than non-H1N1 patients (7.5 years of age vs 4.6 years, P<0.001). Among histories or symptoms of patients with flu-like illness, contact history (80%) with another patient with pandemic influenza (H1N1 2009) was an important clue of the infection in early phase of pandemic. Comparing with hospitalized patients with respiratory tract infections due to other causes, lower ESR (32.9+/-23.5 mm/hour vs 11.5+/-9.2 mm/hour), hyperkalemia (4.2+/-0.3 mmol/L vs 5.2+/-3 mmol/L) and hyponatremia (137.2+/-2.5 mmol/L vs 124+/-40.5 mmol/L) were significant laboratory finding and higher cholesterol and GTP were noticed in pandemic influenza (H1N1 2009). Ten confirmed patients with pandemic influenza (H1N1 2009) were hospitalized due to pneumonia and all of them were resolved without any complication. CONCLUSIONS: Respiratory tract infections were caused not only by pandemic influenza (H1N1 2009) virus but also various respiratory viruses. Hospitalized patients, confirmed as pandemic influenza (H1N1 2009), showed a good prognosis. Age and contact history were distinct features and could be an important clue to differentiate causes in patients with febrile respiratory symptoms.ope

    Juvenile idiopathic arthritis: Diagnosis and differential diagnosis

    Get PDF
    Juvenile idiopathic arthritis (JIA) is comprised of a heterogeneous group of several disease subtypes that are characterized by the onset of arthritis before the age of 16 years and has symptoms lasting at least 6 weeks. The previous classification of JIA included seven different categories, whereas its current classification was compiled by the International League of the Association for Rheumatology, and replaced the previous terms of "juvenile chronic arthritis" and "juvenile rheumatoid arthritis," which were used in Europe or North America, respectively, with the single nomenclature of JIA. As mentioned above, JIA is defined as arthritis of unknown etiology that manifests itself before the age of 16 years and persists for at least 6 weeks, while excluding other known conditions. The clinical symptoms of JIA can be quite variable. Several symptoms that are characteristic of arthritis are not necessarily diagnostic of JIA and may have multiple etiologies that can be differentiated with careful examination of patient history. The disease may develop over days or sometimes weeks, thereby making the diagnosis difficult at the time of presentation. To make a clinical diagnosis of JIA, the first step is to exclude arthritis with known etiologies. Of note, late treatment due to excessive delay of diagnosis can cause severe damage to joints and other organs and impair skeletal maturation. Therefore, early detection of JIA is critical to ensure prompt treatment and to prevent long-term complications including the likelihood of disability in childhoodope
    • …
    corecore